Searched for
API III
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThe spike in crude oil prices has again created trouble for the Nifty and Sensex, as it has done a number of times in the past two months. ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- JM Financial Private Equity, family offices invest Rs 150 cr in NG Electro ProductsConsumer goods-focused NG Electro Products has secured Rs 150 crore in funding from JM Financial Private Equity and family offices. The cap...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Govt extends Atal Pension Yojana till FY 30-31: How much monthly pension can you get under APY?Atal Pension Yojana: A vital monthly pension scheme for millions of Indians, has been extended until the Financial Year 2030-31. The Union ...
- NPS and APY subscriber alert: What PFRDA’s proposal for pension wealth accumulation means for National Pension System, Atal Pension Yojana account holdersPFRDA is proposing a new valuation method for government securities in NPS and APY. This dual framework aims to provide stable pension weal...
- Alembic Pharmaceuticals receives 2 observations for Gujarat facility from USFDAAs per US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when the inves...
- Aadhaar seeding for Atal Pension Yojana (APY) subscribers using CRA portal, mobile: Important features, how to useAPY-SPs can collect the Aadhaar details from their associated subscribers who are their customers with due consent which would then be shar...
- Atal Pension Yojana: How much pension will a subscriber receive under APY?A savings bank account is required to join open APY account. All payments must be made on a monthly basis via auto-debit from the subscribe...
- Lupin recalls over 54K vials of anti-bacterial injection in USThe ongoing voluntary recall is a class III recall and is for the US and Puerto Rico, according to the latest enforcement report on USFDA s...
- Shasun Pharmaceutical’s UK subsidiary would not be impacted from declining sales of IncevikShasun Pharmaceutical’s stock gained 12.6% today after the company came out with an update on its UK subsidiary.
- Dishman to chase high-potency therapiesDishman Pharmaceuticals Ltd, will now focus on the high-potency therapies like steroids, hormones, isotopes and cytotoxics.
Load More
